A new study out of the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center finds lung-sparing pleurectomy/decortication (P/D) surgery has a very low rate of early mortality. These findings are in direct contrast to those from the MARS2 trial, which reported P/D surgery carried[…]
Novel Treatments & Drugs
Tumor Treating Fields to Treat Mesothelioma and Other Hard to Treat Cancers
Tumor treating fields are an innovative new way to treat cancer. They do not involve surgery or drugs. They are also known as TTFields. TTFields have been approved by the FDA for the use of treating mesothelioma. Mesothelioma is a rare and aggressive cancer that affects the lining of certain[…]
Artificial Intelligence and Mesothelioma
Diagnosing lung diseases can be hard because they have many causes and symptoms. Artificial intelligence may enable faster and more accurate diagnosis. AI could potentially play a role in improving outcomes for mesothelioma patients as well as other lung diseases. One common lung problem is pleural effusion. This can make[…]
Photodynamic Therapy to Treat Mesothelioma
Cancer treatment has made significant improvements in recent years, thanks to advancements in technology. One technology being used is 3D printing and scanning. Together they are enhancing the accuracy and effectiveness of cancer treatments. This includes photodynamic therapy for malignant pleural mesothelioma and other cancers. Photodynamic therapy (PDT) is a[…]
Tretinoin and Chemotherapy
Tretinoin is a derivative of vitamin A. It has the potential to enhance the effects of chemotherapy. Combining tretinoin with chemotherapy improved survival rates in mesothelioma in mice. Mesothelioma is a rare cancer that is hard to diagnose and treat. It develops on the thin layer of tissue that surrounds[…]
Serous Fluid Cytology to Diagnose Mesothelioma
Diagnosing mesothelioma, a cancer caused by asbestos exposure, can be a challenging task. One method that is used is serous fluid cytology. It involves examining fluid samples for cancer cells. Doctors also have to distinguish between reactive and cancerous cells, which is difficult. To improve accuracy, doctors may use ancillary[…]
Multimodal Therapy to Treat Mesothelioma
Malignant pleural mesothelioma is a significant health challenge for individuals. Mesothelioma is linked to asbestos exposure and demands innovative treatment strategies. Recent research provides a promising approach to combatting mesothelioma. A multimodal treatment regimen could offer hope and improved outcomes for people battling the disease. A multimodal approach consists of[…]
Genes and Mesothelioma
Scientists studied how asbestos exposure alters the genes of malignant pleural mesothelioma. They published their findings in the Journal of Environmental Pathology, Toxicology, and Oncology. This helped to show how the genes of three tumors form. The study helped to deepen our knowledge of mesothelioma’s genetic changes and their connection[…]
Fibroblasts and Mesothelioma
Malignant mesothelioma, a rare and aggressive cancer mainly caused by asbestos exposure, is a cancer of the lining of certain organs including the lungs, abdomen, heart, and testicles. It is very dangerous because it grows and spreads quickly and treatment options are limited. Asbestos is no longer used widely in[…]
Gene Alterations Resulting from Pleural Mesothelioma
Scientists recently studied how asbestos exposure alters the genes of pleural mesothelioma, with the findings being published in the Journal of Environmental Pathology, Toxicology, and Oncology. This allowed scientists to show how the genes of three tumors in patients form. Overall, the study deepened our knowledge of mesothelioma’s genetic changes[…]
Skip to content